Search Results 941-950 of 11267 for Antifungal Resistance
... resistance and delay disease progression in treating patients with stage IIIC or IV BRAF V600E/K melanoma. Hydroxychloroquine may cause cell death in tumor ...
Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image · Mayo Clinic and Stanford researchers develop ...
Ovarian cancer patients with resistance to at least one platinum-based therapy defined according to GCIG. Disease progression during or within 6 months of ...
... fungal infections. People with this disease are often at risk of conditions ... resistance, antibiotics have been presumed safe by most pediatricians ...
This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...
Doctors may also switch among different antibiotics to help prevent bacterial resistance. Antibiotics wipe out most intestinal bacteria, both normal and ...
Hrizat AS, Lin R, Eberle-Singh J, O'Neill R, Xia Y, Testa JR, Uzzo R, McCue PA, Yang H, Li L. Tumor infiltrating T-cells and loss of expression of SWI/SNF ...
... fungal infections such as histoplasmosis or ... resistance are <5%. Subjects from regions with ... Subjects from regions with higher rates of primary multidrug TB ...
Any active Grade 3 or higher (according to NCI CTCAE version 4.03) viral, bacterial, or fungal infection within 2 weeks of the first dose of the study drug.
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.